Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

  • Showing results for a modified search because your search retrieved no results.
1.

Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome.

Ezeh U, Yildiz BO, Azziz R.

J Clin Endocrinol Metab. 2013 Jun;98(6):E1088-96. doi: 10.1210/jc.2013-1295. Epub 2013 Mar 28.

2.

Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis.

Lizneva D, Kirubakaran R, Mykhalchenko K, Suturina L, Chernukha G, Diamond MP, Azziz R.

Fertil Steril. 2016 Nov;106(6):1510-1520.e2. doi: 10.1016/j.fertnstert.2016.07.1121. Epub 2016 Aug 13. Review.

PMID:
27530062
3.

Referral bias in female functional hyperandrogenism and polycystic ovary syndrome.

Luque-Ramírez M, Alpañés M, Sanchón R, Fernández-Durán E, Ortiz-Flores AE, Escobar-Morreale HF.

Eur J Endocrinol. 2015 Nov;173(5):603-10. doi: 10.1530/EJE-15-0646. Epub 2015 Aug 4.

4.

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.

Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R.

J Clin Endocrinol Metab. 1998 Sep;83(9):3078-82.

PMID:
9745406
5.

Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.

Zhang HY, Guo CX, Zhu FF, Qu PP, Lin WJ, Xiong J.

Arch Gynecol Obstet. 2013 Mar;287(3):525-31. doi: 10.1007/s00404-012-2568-z. Epub 2012 Oct 30.

PMID:
23108387
6.

The prevalence and features of the polycystic ovary syndrome in an unselected population.

Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO.

J Clin Endocrinol Metab. 2004 Jun;89(6):2745-9.

PMID:
15181052
7.

Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.

Alvarez-Blasco F, Botella-Carretero JI, San Millán JL, Escobar-Morreale HF.

Arch Intern Med. 2006 Oct 23;166(19):2081-6.

PMID:
17060537
8.

Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations.

Welt CK, Arason G, Gudmundsson JA, Adams J, Palsdóttir H, Gudlaugsdóttir G, Ingadóttir G, Crowley WF.

J Clin Endocrinol Metab. 2006 Nov;91(11):4361-8. Epub 2006 Aug 29.

PMID:
16940441
9.

[Polycystic ovary syndrome: is there a rise in the prevalence?].

Carmona-Ruiz IO, Saucedo-de la Llata E, Moraga-Sánchez MR, Romeu-Sarró A.

Ginecol Obstet Mex. 2015 Dec;83(12):750-9. Spanish.

PMID:
27290799
10.

Impact of obesity on the risk for polycystic ovary syndrome.

Yildiz BO, Knochenhauer ES, Azziz R.

J Clin Endocrinol Metab. 2008 Jan;93(1):162-8. Epub 2007 Oct 9.

11.

Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.

Yildiz BO, Bozdag G, Yapici Z, Esinler I, Yarali H.

Hum Reprod. 2012 Oct;27(10):3067-73. doi: 10.1093/humrep/des232. Epub 2012 Jul 9.

PMID:
22777527
12.

Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.

Kim JJ, Chae SJ, Choi YM, Hwang KR, Song SH, Yoon SH, Kim SM, Ku SY, Kim SH, Kim JG, Moon SY.

Hum Reprod. 2013 May;28(5):1354-60. doi: 10.1093/humrep/det057. Epub 2013 Mar 10.

PMID:
23477907
13.

Prevalence of polycystic ovary syndrome in women in China: a large community-based study.

Li R, Zhang Q, Yang D, Li S, Lu S, Wu X, Wei Z, Song X, Wang X, Fu S, Lin J, Zhu Y, Jiang Y, Feng HL, Qiao J.

Hum Reprod. 2013 Sep;28(9):2562-9. doi: 10.1093/humrep/det262. Epub 2013 Jun 27.

PMID:
23814096
14.

The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome.

Moran LJ, Ranasinha S, Zoungas S, McNaughton SA, Brown WJ, Teede HJ.

Hum Reprod. 2013 Aug;28(8):2276-83. doi: 10.1093/humrep/det256. Epub 2013 Jun 15.

PMID:
23771201
15.

Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.

Graff SK, Mário FM, Alves BC, Spritzer PM.

Fertil Steril. 2013 Oct;100(4):1081-8. doi: 10.1016/j.fertnstert.2013.06.005. Epub 2013 Jul 2.

PMID:
23830153
16.

Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.

Panidis D, Tziomalos K, Misichronis G, Papadakis E, Betsas G, Katsikis I, Macut D.

Hum Reprod. 2012 Feb;27(2):541-9. doi: 10.1093/humrep/der418. Epub 2011 Dec 5.

PMID:
22144419
17.

Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.

Schmidt TH, Khanijow K, Cedars MI, Huddleston H, Pasch L, Wang ET, Lee J, Zane LT, Shinkai K.

JAMA Dermatol. 2016 Apr;152(4):391-8. doi: 10.1001/jamadermatol.2015.4498.

PMID:
26720591
18.

Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.

Alpañés M, Luque-Ramírez M, Martínez-García MÁ, Fernández-Durán E, Álvarez-Blasco F, Escobar-Morreale HF.

Fertil Steril. 2015 Mar;103(3):795-801.e2. doi: 10.1016/j.fertnstert.2014.12.105. Epub 2015 Jan 10.

PMID:
25585504
19.

Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.

Li L, Chen X, He Z, Zhao X, Huang L, Yang D.

J Pediatr Adolesc Gynecol. 2012 Dec;25(6):390-5. doi: 10.1016/j.jpag.2012.07.006. Epub 2012 Oct 22.

PMID:
23089573
20.

Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome.

Zhao X, Zhong J, Mo Y, Chen X, Chen Y, Yang D.

Int J Gynaecol Obstet. 2010 Feb;108(2):148-51. doi: 10.1016/j.ijgo.2009.09.021. Epub 2009 Nov 25.

PMID:
19932893

Supplemental Content

Support Center